Reinforcing its commitment to making world-class eye care accessible to all, Sankara Eye Hospital, one of India’s foremost ...
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA"), a Phase 3 immuno-oncology company developing novel therapeutics to ...
Alithya Group inc. (TSX: ALYA) ("Alithya" or the "Company") reported today its results for the second quarter of fiscal 2026 ended September 30, 2025. All amounts are in Canadian dollars unless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback